InterCure to Release its Q2 2022 Results and Hold a Conference Call
August 11 2022 - 10:30AM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure" or the “Company”) today announced that it
plans to release financial results for the second quarter of 2022
after market close on Monday, August 15, 2022.
InterCure executives will host a live conference
call and audio webcast to discuss these results on Tuesday, August
16, 2022, at 8:30 am Eastern Time, details of which are provided
below.
To access the conference call, participants can
register through the following URL:
https://register.vevent.com/register/BI5e6af40482ac4b7bb3024b6aad2c8185.
Once registered participants will receive dials and
a unique pin which will allow them to access the call.
A replay of the conference call will be available
through the following Webcast link:
https://edge.media-server.com/mmc/p/gm9sadgn, or through the
‘Events and Presentations’ section of the InterCure website at
http://www.intercure.co.
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief
Financial Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From May 2024 to Jun 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Jun 2023 to Jun 2024